Drägerwerk AG & Co. KGaA (DWRKF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Drägerwerk AG & Co. KGaA (DWRKF) trades at $543.70 with AI Score 49/100 (Grade C). Drägerwerk AG & Co. KGaA is a German company specializing in medical and safety technology. Market cap: $1.75B, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for DWRKF: DWRKF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DWRKF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
DWRKF: the 1 perspectives are evenly split.
How is this calculated? →Drägerwerk AG & Co. KGaA (DWRKF) Healthcare & Pipeline Overview
Drägerwerk AG & Co. KGaA, founded in 1889, is a global leader in medical and safety technology, offering a diverse portfolio of products and services ranging from acute care solutions to personal protection equipment, serving both healthcare and industrial sectors with a strong presence in Europe, the Americas, Asia, and Australia.
What Is the Investment Thesis for DWRKF?
Drägerwerk AG & Co. KGaA presents a compelling investment case based on its established market position and diversified product portfolio. The company's focus on both medical and safety technology provides resilience across economic cycles. Growth catalysts include increasing demand for advanced medical equipment and stringent safety regulations in industrial sectors. The company's P/E ratio of 10.6, as of 2026-03-15, suggests a potentially undervalued opportunity compared to its peers. The company's beta of -0.19 indicates lower volatility than the market, making it a noteworthy option for risk-averse investors. However, investors should monitor the impact of currency fluctuations and raw material costs on profitability.
Based on FMP financials and quantitative analysis
DWRKF Key Highlights
- Drägerwerk AG & Co. KGaA operates in the medical and safety technology sectors, providing a diversified revenue stream.
- The company's global presence across Europe, the Americas, Africa, Asia, and Australia reduces regional risk.
- Drägerwerk's product portfolio includes both medical devices and safety equipment, offering resilience to sector-specific downturns.
- The company's P/E ratio of 10.6 suggests a potentially attractive valuation compared to industry peers.
- A beta of -0.19 indicates lower volatility compared to the broader market.
Who Are DWRKF's Competitors?
DWRKF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIESF Biotest AG | $32.00 | +0.00% | $1.60B | 48 |
| BITGF Biotage AB (publ) | $15.01 | +0.00% | $1.20B | 52 |
| CMPUY CompuGroup Medical SE & Co. KGaA | $23.00 | -7.26% | $1.19B | 48 |
| CMPVF CompuGroup Medical SE & Co. KGaA | $33.66 | +11.64% | $1.74B | 48 |
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DWRKF's Key Strengths?
- Diversified product portfolio across medical and safety technology.
- Global presence and distribution network.
- Strong brand reputation and established market position.
- Focus on innovation and technological leadership.
What Are DWRKF's Weaknesses?
- Exposure to currency fluctuations.
- Dependence on regulatory approvals.
- Competition from larger players in certain market segments.
- Potential for product liability claims.
What Could Drive DWRKF Stock Higher?
- Potential new product launches in medical devices sector.
- Increasing demand for safety equipment due to stricter regulations.
- Expansion into emerging markets with growing healthcare infrastructure.
- Potential partnerships to expand product offerings.
- Continued innovation in gas detection technologies.
What Are the Key Risks for DWRKF?
- Economic downturns affecting healthcare spending.
- Changes in government regulations impacting medical device approvals.
- Exposure to currency fluctuations.
- Increased competition from low-cost manufacturers.
- Product liability claims.
What Are the Growth Opportunities for DWRKF?
- Growth opportunity 1: Expansion in emerging markets represents a significant growth opportunity for Drägerwerk. Increasing healthcare spending and industrialization in regions like Asia-Pacific and Latin America create demand for the company's medical and safety solutions. By tailoring its product offerings and distribution strategies to local needs, Drägerwerk can capture a larger share of these rapidly growing markets. This expansion could contribute to a 10-15% increase in revenue over the next five years.
- Growth opportunity 2: The increasing adoption of digital health technologies presents an opportunity for Drägerwerk to integrate its medical devices with software platforms and data analytics. By offering connected solutions that improve patient monitoring, enhance clinical decision-making, and streamline healthcare workflows, Drägerwerk can differentiate itself from competitors and capture a larger share of the digital health market. The digital health market is projected to reach $379 billion by 2024.
- Growth opportunity 3: The growing emphasis on workplace safety and environmental protection drives demand for Drägerwerk's safety equipment and gas detection solutions. Stricter regulations and increased awareness of workplace hazards create opportunities for the company to expand its sales to industries such as oil and gas, mining, and construction. Focusing on innovative gas detection technologies and comprehensive safety training programs can strengthen Drägerwerk's position in this market.
- Growth opportunity 4: Strategic acquisitions and partnerships can accelerate Drägerwerk's growth by expanding its product portfolio, entering new markets, and gaining access to innovative technologies. By acquiring companies with complementary products or technologies, Drägerwerk can strengthen its competitive position and offer a more comprehensive suite of solutions to its customers. Targeted acquisitions in areas such as remote patient monitoring and industrial safety can drive significant growth.
- Growth opportunity 5: The increasing demand for home healthcare solutions presents an opportunity for Drägerwerk to develop and market medical devices and monitoring systems for use in the home. As the population ages and healthcare costs rise, there is a growing need for affordable and convenient home healthcare solutions. By offering user-friendly medical devices and remote monitoring services, Drägerwerk can tap into this growing market and improve the quality of life for patients.
What Opportunities Does DWRKF Have?
- Expansion in emerging markets.
- Increasing adoption of digital health technologies.
- Growing emphasis on workplace safety and environmental protection.
- Strategic acquisitions and partnerships.
What Threats Does DWRKF Face?
- Economic downturns affecting healthcare spending.
- Changes in government regulations.
- Technological disruptions from new entrants.
- Increased competition from low-cost manufacturers.
What Are DWRKF's Competitive Advantages?
- Strong brand reputation and established market position.
- Diversified product portfolio across medical and safety technology.
- Global presence and distribution network.
- Focus on innovation and technological leadership.
What Does DWRKF Do?
Drägerwerk AG & Co. KGaA, established in Lübeck, Germany in 1889, has evolved into a prominent player in the medical and safety technology sectors. Initially focused on respiratory and diving equipment, the company expanded its portfolio to include a comprehensive range of products and services for acute point of care, such as emergency care, perioperative care, critical care, and perinatal care. This includes anesthesia devices, ventilators, thermoregulation equipment, patient monitoring systems, and related consumables and accessories. Drägerwerk also caters to the safety needs of various industries and public sectors. Their offerings encompass personal protective equipment, gas detection technology, and integrated hazard management solutions for industries like mining, as well as public services like fire departments and disaster protection agencies. These products include stationary and mobile gas detection systems, alcohol and drug testing devices, and fire training facilities. With a global footprint spanning Europe, the Americas, Africa, Asia, and Australia, Drägerwerk AG & Co. KGaA serves a diverse clientele across healthcare, industrial, and public sectors. The company's commitment to innovation and quality has solidified its position as a trusted provider of critical medical and safety solutions worldwide.
What Products and Services Does DWRKF Offer?
- Develops and markets system solutions for acute point of care, including emergency, perioperative, critical, and perinatal care.
- Provides anesthesia devices and ventilators.
- Offers thermoregulation equipment, consumables, and accessories.
- Supplies gas management systems and patient monitoring solutions.
- Develops and markets personal protective equipment for industrial and public sectors.
- Offers stationary and mobile gas detection systems.
- Provides alcohol and drug testing devices.
- Offers training and services, including fire training facilities.
How Does DWRKF Make Money?
- Develops and manufactures medical and safety technology products.
- Sells products and services directly to hospitals, industrial clients, and public sector organizations.
- Generates revenue from product sales, service contracts, and training programs.
- Focuses on innovation and quality to maintain a competitive advantage.
What Industry Does DWRKF Operate In?
Drägerwerk AG & Co. KGaA operates within the medical devices and safety equipment industries, both experiencing steady growth driven by technological advancements, aging populations, and increasing safety regulations. The medical device market is projected to reach $600 billion by 2025, while the safety equipment market is expected to reach $60 billion. Drägerwerk competes with major players like ARHCF (Arjo), BIESF (B. Braun), and CMPUY (Coloplast), focusing on innovation and specialized solutions to maintain its competitive edge. The company's diversified portfolio allows it to capitalize on growth opportunities in both sectors.
Who Are DWRKF's Key Customers?
- Hospitals and healthcare providers
- Industrial companies in sectors such as mining, oil and gas, and construction
- Public sector organizations, including fire departments, police, and disaster protection agencies
Drägerwerk AG & Co. KGaA (DWRKF) Valuation Context
Valued at $1.75B, DWRKF is classified as a small-cap stock. Relative to its peer group, DWRKF's quantitative score of 49/100 is roughly in line with the peer average of 54/100.
ROE 10%Key Financial Metrics
Return on equity for Drägerwerk AG & Co. KGaA stands at 9.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.8%, showing how much profit it generates from its asset base. DWRKF trades at a trailing price-to-earnings ratio of 10.59, below the Healthcare sector average of ~23x. Its free cash flow yield is 10.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.07 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 9.9%, the inverse of the P/E and a quick read on earnings relative to price.
DWRKF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified product portfolio across medical and safety technology.
- Global presence and distribution network.
- Strong brand reputation and established market position.
- Focus on innovation and technological leadership.
Bear Case
- Exposure to currency fluctuations.
- Dependence on regulatory approvals.
- Competition from larger players in certain market segments.
- Potential for product liability claims.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
DWRKF Latest News
No recent news available for DWRKF.
DWRKF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DWRKF.
Price Targets
Wall Street price target analysis for DWRKF.
DWRKF MoonshotScore
What does this score mean?
The MoonshotScore rates DWRKF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Stefan A. Drager
Unknown
Information on Stefan A. Drager's specific background, career history, education, and previous roles is not available in the provided data. However, as CEO, he is responsible for managing the overall strategic direction and operations of Drägerwerk AG & Co. KGaA, a company with over 15,000 employees.
Track Record: Due to the limited information available, it is not possible to provide specific details on Stefan A. Drager's key achievements, strategic decisions, or company milestones under his leadership. His role involves overseeing the company's activities in medical and safety technology across multiple global markets.
DWRKF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Drägerwerk AG & Co. KGaA may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack stringent listing standards, resulting in increased risks for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Increased price volatility.
- Potential for fraud or manipulation.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review any available analyst reports or independent research.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- The company has been in operation since 1889.
- Drägerwerk AG & Co. KGaA has a global presence.
- The company operates in the regulated medical and safety technology sectors.
- The company has a diverse product portfolio.
- The company has a large number of employees (15,170).
DWRKF Healthcare Stock FAQ
What does Drägerwerk AG & Co. KGaA do?
Drägerwerk AG & Co. KGaA is a global leader in medical and safety technology. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. They also provide personal protection equipment, gas detection technology, and integrated hazard management solutions for various industries and public sectors. Their comprehensive product portfolio and global presence make them a key player in both the healthcare and safety markets.
What are the main risks for DWRKF?
Drägerwerk AG & Co. KGaA faces several risks, including economic downturns affecting healthcare spending, changes in government regulations impacting medical device approvals, and exposure to currency fluctuations due to its global operations. Increased competition from low-cost manufacturers and potential product liability claims also pose significant risks. Investors should carefully consider these factors before investing in DWRKF.
What are the key factors to evaluate for DWRKF?
Drägerwerk AG & Co. KGaA (DWRKF) holds an AI score of 49/100 (low). P/E: 10.6x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does DWRKF data refresh on this page?
DWRKF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven DWRKF's recent stock price performance?
Drägerwerk AG & Co. KGaA (DWRKF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio across medical and safety technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DWRKF overvalued or undervalued right now?
Drägerwerk AG & Co. KGaA (DWRKF) trades at 10.6x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying DWRKF?
Before investing in Drägerwerk AG & Co. KGaA (DWRKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding DWRKF to a portfolio?
Key strength of Drägerwerk AG & Co. KGaA (DWRKF): Diversified product portfolio across medical and safety technology. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2026-03-15.
- OTC market data may have limited availability and reliability.
- AI analysis pending for DWRKF.